Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 25 or more amino acid residues in defined sequence
Patent
1993-06-07
1995-11-07
Nucker, Christine M.
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
25 or more amino acid residues in defined sequence
530325, 530326, 435 5, 435974, A61K 3702
Patent
active
054649331
ABSTRACT:
The present invention relates to peptides which exhibit potent anti-retroviral activity. The peptides of the invention comprise DP-178 (SEQ ID:1) ptides corresponding to amino acids 638 to 673 of the HIV-1.sub.LAI gp41 protein, and fragments, analogs and homologs of DP-178. The invention further relates to the uses of such peptides as inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells.
REFERENCES:
patent: 5141867 (1992-08-01), Ivanoff et al.
Wild et al., 1992, A synthetic peptide inhibitor of human immunodeficiency virus replication: Correlation between solution structure and viral inhibition, Proc. Natl. Acad. Sci USA 89:10537-10541.
Mitsuya et al., 1991, Targeted therapy of human immunodeficiency virus-related disease, FASEB J. 5:2369-2381.
Hammarskjold and Rekosh, 1989, The molecular biology of the human immunodeficiency virus, Biochem. Biophys. Acta 989:269-280.
Guyader et al., 1987, Genome organization and transactivation of the human immunodeficiency virus type 2, Nature 326:662-669.
Clavel et al., 1986, Isolation of a new human retrovirus from west african patients with AIDS, Science 233:343-346.
Maddon et al., 1986, The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain, Cell 47:333-348.
McDougal et al., 1986, Binding of HTLV-III/LAV to T4+T cells by a complex of the 110k viral protein and the T4 molecule, Science 231:382-385.
Brain et al., 1985, Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients, Science 228:1094-1096.
Dalgleish et al., 1984, The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus, Nature 312:763-767.
Gallo et al., 1984, Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS, Science 224:500-503.
Klatzmann et al., 1984, T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV, Nature 312:767-768.
Teich et al., 1984, Pathogenesis of lentivirus, in "RNA Tumor Viruses," Weiss et al., eds., CSH-Press, pp. 949-956.
Barre-Sinoussi et al., 1983, Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS), Science 220:868-870.
Bolognesi Dani P.
Matthews Thomas J.
Wild Carl T.
Duke University
Nucker Christine M.
Stucker Jeffrey
LandOfFree
Synthetic peptide inhibitors of HIV transmission does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthetic peptide inhibitors of HIV transmission, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic peptide inhibitors of HIV transmission will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-198187